Clincosm LogoSign in Get a demo

Triple Negative Breast Cancer

Showing NaN - NaN of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Advanced Solid Tumor, Advanced Cancer, Triple Negative Breast Cancer Trial in Nashville, Houston, San Antonio (NBE-002)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Nashville, Tennessee
  • +2 more
Mar 3, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Advanced Solid Tumors, Triple Negative Breast Cancer Trial in Houston, Beijing (TT-00420)

Active, not recruiting
  • Advanced Solid Tumors
  • Triple Negative Breast Cancer
  • Houston, Texas
  • +1 more
Oct 25, 2021

Advanced Solid Tumors, Metastatic Colon Cancer, Metastatic Breast Cancer Trial in United States (Fruquintinib (HMPL-013))

Recruiting
  • Advanced Solid Tumors
  • +6 more
  • Fruquintinib (HMPL-013)
  • Phoenix, Arizona
  • +8 more
Aug 30, 2021

Solid Tumor, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in United States (ZN-c3)

Recruiting
  • Solid Tumor
  • +9 more
  • Tucson, Arizona
  • +3 more
Aug 12, 2021

Triple Negative Breast Cancer, Pancreatic Carcinoma, Melanoma Trial in Worldwide (MCS110, PDR001)

Completed
Has Results
  • Triple Negative Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +19 more
Jul 12, 2021

Breast Cancer, Triple Negative Breast Cancer Trial in Houston, Sugar Land (Everolimus)

Completed
Has Results
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Houston, Texas
  • +2 more
Jul 16, 2021

Breast Cancer Stage IV, Triple Negative Breast Cancer, Breast Tumors Trial in Houston (Sitravatinib)

Recruiting
  • Breast Cancer Stage IV
  • +3 more
  • Houston, Texas
    Baylor College of Medicine
Jun 1, 2021

Triple Negative Breast Cancer Trial in Worldwide (Cyclophosphamide, Placebo, Doxorubicin)

Completed
  • Triple Negative Breast Cancer
  • Scottsdale, Arizona
  • +157 more
Jan 15, 2021

Triple Negative Breast Cancer, Head & Neck Cancer, Esophageal Cancer Trial in Worldwide (PCA062)

Completed
  • Triple Negative Breast Cancer
  • +2 more
  • Houston, Texas
  • +6 more
Dec 16, 2020

Triple Negative Breast Cancer Trial in United States (GTx-024)

Terminated
Has Results
  • Triple Negative Breast Cancer
  • Fort Lauderdale, Florida
  • +6 more
Oct 29, 2020

Colorectal Cancer, Triple Negative Breast Cancer, Pancreatic Cancer Trial in Denver, Miami, Houston (Toca 511, Toca FC)

Terminated
  • Colorectal Cancer
  • +11 more
  • Toca 511
  • Toca FC
  • Denver, Colorado
  • +2 more
Feb 5, 2020

Breast Cancer, Triple Negative Breast Cancer, Emotions Trial in Houston (Standard of Care + Experimental Individualized Therapy,

Completed
  • Breast Cancer
  • +3 more
  • Standard of Care + Experimental Individualized Therapy
  • Control: Standard of Care
  • Houston, Texas
  • +1 more
Aug 26, 2019

Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer Trial in United States (Abraxane alone, Abraxane +

Completed
Has Results
  • Breast Cancer
  • +3 more
  • Abraxane alone
  • Abraxane + Tigatuzumab
  • Birmingham, Alabama
  • +9 more
Oct 24, 2017

Estrogen Receptor Negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Triple Negative Breast

Terminated
Has Results
  • Estrogen Receptor Negative Breast Cancer
  • +5 more
  • Birmingham, Alabama
  • +15 more
May 22, 2017

Breast Cancer, HER-2 Positive Breast Cancer, Triple Negative Breast Cancer Trial in Worldwide (ganetespib)

Completed
  • Breast Cancer
  • +3 more
  • Birmingham, Alabama
  • +24 more
Nov 4, 2015

Triple Negative Breast Cancer Biomarker Study

Completed
  • Metastatic Breast Cancer
  • Triple Negative Breast Cancer
    • Denver, Colorado
    • +17 more
    Jul 19, 2013